Introducing the new AltIndexLearn more
BioXcel Therapeutics

BioXcel Therapeutics (BTAI) Earnings Prediction

Updated August 11, 2026 · AltIndex alt-data view going into the print

AltIndex AI Score on BioXcel Therapeutics is 40 — signals are mixed heading into the print. Underlying trend: 4 tracked signals showing mixed direction over the last 3 months.

Next report
Monday, August 10, 2026
EPS Estimate
$-0.58
AltIndex AI Score
40
AI Prediction
Mixed signals

BTAI stock price — last 3 months

BioXcel Therapeutics (BTAI) is trading at $0.93, down 21.8% over the last 3 months (from $1.19 three months ago).

What the alt-data signals say about BioXcel Therapeutics right now

Trends across the last 3 months — the run-up to BioXcel Therapeutics’s next earnings print.

Signal Current 3-month change
Job postings 0 No 3-month baseline
LinkedIn headcount 53 ↓ -3.6%
Sentiment 85% Bullish → flat
Web traffic 7,380 ↑ +14.1%
Employee business outlook 20% Negative → flat

Full daily-resolution trend charts on every signal are on the BTAI ticker page.

Get alerted when BTAI signals inflect

AltIndex stock alerts fire when alt-data on BTAI breaks out — web traffic spike, hiring surge, sentiment shift — often days before the earnings number confirms it.

Sign up to AltIndex →

BioXcel Therapeutics earnings: frequently asked questions

When does BioXcel Therapeutics report earnings next?
BioXcel Therapeutics (BTAI) is scheduled to report next earnings on Monday, August 10, 2026. The exact pre-market or post-market time is set by the company a few days ahead; see the official investor-relations page for confirmation.
What does the AltIndex AI Score say about BioXcel Therapeutics going into earnings?
Current AI Score on BioXcel Therapeutics: 40 — Mixed signals. The AI Score combines 10,000+ alternative-data and financial signals into one 0–100 number; higher = signals lean bullish, lower = signals lean bearish. Full per-signal breakdown is on the BTAI ticker page.
What is the EPS estimate for BioXcel Therapeutics?
Analyst consensus EPS estimate for BioXcel Therapeutics’s next quarter: $-0.58. We refresh this from analyst-estimate data daily.
How accurate are AltIndex’s earnings predictions for BioXcel Therapeutics?
AltIndex doesn’t predict the exact EPS number — the alt-data signals don’t see the financials. What the signals can do is tell you whether the underlying business momentum (web traffic, hiring, social audience, sentiment) supports the analyst consensus or contradicts it. AltIndex publishes the full pick history at altindex.com/results — including the misses — so you can verify how the signal-driven calls have performed.
Where can I see the full signal breakdown on BioXcel Therapeutics?
Visit https://altindex.com/ticker/btai for the complete per-signal view: AI Score history, web traffic trend chart, 8-platform social audience tracking, hiring activity, news mention volume, sentiment scoring, insider trades and Congressional disclosures.
How can I get alerted before BioXcel Therapeutics reports earnings?
AltIndex stock alerts fire when alt-data signals on a stock break out of their historical range — often days or weeks before the earnings number confirms it. Add BTAI to your watchlist and you’ll get notified when its signals shift. See altindex.com/stock-alerts for the full alert categories.

See every alt-data signal on BTAI

Sign up to see the full daily-resolution trend charts on every signal AltIndex tracks for BioXcel Therapeutics — web traffic, hiring, 8-platform social audience, sentiment, insider trades and the full AI Score breakdown.

Sign up to AltIndex → Log in